Fig. 3From: Epigenetic modulators as therapeutic targets in prostate cancerEpigenetic modifying drugs. This figure illustrates several epigenetic compounds classified accordingly to their respective epigenetic target that have been reported as having a role on PCa cell phenotype reversion either in pre-clinical or clinical assaysBack to article page